Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage
- 1 July 2018
- journal article
- conference paper
- Published by Elsevier in Experimental Gerontology
- Vol. 107, 116-125
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute on Aging (R01 AG048023)
- Northern Ontario Heritage Fund Corporation (A-17-07)
This publication has 70 references indexed in Scilit:
- The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccinesVaccine, 2012
- Granzyme B-Dependent Proteolysis Acts as a Switch to Enhance the Proinflammatory Activity of IL-1αMolecular Cell, 2011
- Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccineVaccine, 2011
- Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humansVaccine, 2011
- Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humansVaccine, 2010
- Clinical and immunologic predictors of influenza illness among vaccinated older adultsVaccine, 2010
- IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cellsCellular Immunology, 2009
- Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjectsVaccine, 2007
- Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytesMechanisms of Ageing and Development, 2007
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004